Invention Grant
US08168609B2 RNAi-mediated inhibition of Rho kinase for treatment of ocular disorders
失效
RNAi介导的Rho激酶抑制治疗眼部疾病
- Patent Title: RNAi-mediated inhibition of Rho kinase for treatment of ocular disorders
- Patent Title (中): RNAi介导的Rho激酶抑制治疗眼部疾病
-
Application No.: US12940375Application Date: 2010-11-05
-
Publication No.: US08168609B2Publication Date: 2012-05-01
- Inventor: Jon E. Chatterton , Abbot F. Clark
- Applicant: Jon E. Chatterton , Abbot F. Clark
- Applicant Address: US TX Fort Worth
- Assignee: Alcon Research, Ltd.
- Current Assignee: Alcon Research, Ltd.
- Current Assignee Address: US TX Fort Worth
- Agent Jason J. Derry
- Main IPC: C12N15/11
- IPC: C12N15/11 ; C07H21/02
Abstract:
RNA interference is provided for inhibition of Rho kinase mRNA expression for treating patients with ocular disorders, particularly for treating intraocular pressure, ocular hypertension and glaucoma. Rho kinase mRNA targets include mRNA for ROCK1 and ROCK2.
Public/Granted literature
- US20110245319A1 RNAi-Mediated Inhibition of RHO Kinase for Treatment of Ocular Disorders Public/Granted day:2011-10-06
Information query
IPC分类:
